REPLIX 分数是由锐璞团队独创的一个衡量美股中小医药企业的框架。这个框架覆盖了评估中小药企的6个重要因素。这6个因素正好可以用REPLIX 6个字母来表达。REPLIX分数是锐璞投资流程的一个重要组成部分,可以优化选股过程,避开投资风险。
REPLIX 分数六大要素
Risk/Reward Ratio
(风险收益比例)
Events/Catalyst
(近期催化剂)
Product / Pipeline
(研发管线)
Long Term Financial Strength
(长期财务状况)
Institution Support / Insider Ownership
(知名机构以及管理层持股情况)
X - X factor
(市场热点)
股票 代码 |
公司 名称 |
Replix 分数 |
R - Risk/ Reward Ratio |
E - Events/ Catalyst |
P - Product/ Pipeline |
L - Long Term/ Financial Strength |
I - Inst. Support/ Insider Ownership |
X - X factor |
更新 时间 |
---|---|---|---|---|---|---|---|---|---|
NTLA | Intellia Therapeutics Inc | * | * | * | * | * | * | * | 2022-04-03 |
BCYC | Bicycle Therapeutics | * | * | * | * | * | * | * | 2022-04-03 |
XENE | Xenon Pharmaceuticals | * | * | * | * | * | * | * | 2022-04-02 |
ARWR | Arrowhead Pharmaceuticals Inc | * | * | * | * | * | * | * | 2022-03-31 |
KRYS | Krystal Biotech | * | * | * | * | * | * | * | 2022-03-31 |
ARVN | Arvinas Inc | * | * | * | * | * | * | * | 2022-03-31 |
IOVA | Iovance Biotherapeutics | * | * | * | * | * | * | * | 2022-03-31 |
AXSM | Axsome Therapeutics | * | * | * | * | * | * | * | 2022-03-31 |
ASND | Ascendis Pharma A/S | * | * | * | * | * | * | * | 2022-03-30 |
APLS | Apellis Pharmaceuticals Inc | * | * | * | * | * | * | * | 2022-03-30 |